ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,588.71
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Pfizer Inc (0Q1N)

  7. Pfizer Inc (0Q1N) News

Pfizer (0Q1N)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q1N
DateTimeSourceHeadlineSymbolCompany
29/10/202414:31Alliance NewsAlliance NewsHundreds of blood cancer patients to benefit from new Pfizer treatmentLSE:0Q1NPfizer Inc
29/10/202411:46Alliance NewsAlliance NewsTOP NEWS: Pfizer swings to third-quarter profit as Paxlovid sales jumpLSE:0Q1NPfizer Inc
03/10/202416:29Alliance NewsAlliance NewsIN BRIEF: Haleon buys GBP230 million in shares from PfizerLSE:0Q1NPfizer Inc
01/10/202409:03Alliance NewsAlliance NewsUPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion saleLSE:0Q1NPfizer Inc
30/09/202420:59Alliance NewsAlliance NewsTOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake saleLSE:0Q1NPfizer Inc
25/09/202412:49Alliance NewsAlliance NewsPfizer, Moderna and BioNTech take patent fight to Court of AppealLSE:0Q1NPfizer Inc
16/09/202410:00Alliance NewsAlliance NewsPfizer hails positive results from two cancer treatment studiesLSE:0Q1NPfizer Inc
30/07/202411:35Alliance NewsAlliance NewsTOP NEWS: Pfizer ups outlook amid first revenue hike since Covid boostLSE:0Q1NPfizer Inc
01/05/202412:42Alliance NewsAlliance NewsTOP NEWS: Pfizer profit declines on lower Covid-related salesLSE:0Q1NPfizer Inc
23/04/202405:27Alliance NewsAlliance NewsModerna, Pfizer/BioNTech set for UK court clash over Covid jab patentsLSE:0Q1NPfizer Inc
09/04/202417:41Alliance NewsAlliance NewsPfizer RSV treatment meets targets in trial of adults under age 60LSE:0Q1NPfizer Inc
21/03/202416:29Alliance NewsAlliance NewsTOP NEWS: Haleon buys back shares worth GBP315 million from PfizerLSE:0Q1NPfizer Inc
19/03/202410:17Alliance NewsAlliance NewsHaleon to buy back shares from Pfizer for GBP315 millionLSE:0Q1NPfizer Inc
18/03/202408:47Alliance NewsAlliance NewsTOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in HaleonLSE:0Q1NPfizer Inc
13/03/202416:28Alliance NewsAlliance NewsIN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcalLSE:0Q1NPfizer Inc
01/03/202418:27Alliance NewsAlliance NewsPfizer targets eight blockbuster drugs by 2030 in new oncology planLSE:0Q1NPfizer Inc
30/01/202412:56Alliance NewsAlliance NewsTOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boostLSE:0Q1NPfizer Inc
29/01/202408:26Alliance NewsAlliance NewsAstellas and Pfizer's Padcev validated by EMA to treat bladder cancerLSE:0Q1NPfizer Inc
09/01/202413:49Alliance NewsAlliance NewsPfizer's licence application accepted for priority review of TivdakLSE:0Q1NPfizer Inc
08/01/202418:09Alliance NewsAlliance NewsIN BRIEF: Pfizer wins European approval for prostate cancer treatmentLSE:0Q1NPfizer Inc
19/12/202314:13Alliance NewsAlliance NewsTOP NEWS: Pfizer sues Poland and Hungary over Covid debtsLSE:0Q1NPfizer Inc
18/12/202311:04Alliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0Q1NPfizer Inc
13/12/202316:11Alliance NewsAlliance NewsTOP NEWS: Pfizer shares slide as 2024 revenue outlook underwhelmsLSE:0Q1NPfizer Inc
12/12/202312:35Alliance NewsAlliance NewsPfizer's USD43 billion Seagen buy given regulatory nodLSE:0Q1NPfizer Inc
11/12/202309:08Alliance NewsAlliance NewsPfizer's Elrexfio wins EU approval for form of multiple myelomaLSE:0Q1NPfizer Inc
01/12/202316:54Alliance NewsAlliance NewsTOP NEWS: Pfizer rethinks weight loss pill after high side effect rateLSE:0Q1NPfizer Inc
15/11/202305:55Alliance NewsAlliance NewsPfizer to axe 500 jobs at Kent site amid cost-cutting programmeLSE:0Q1NPfizer Inc
31/10/202311:45Alliance NewsAlliance NewsTOP NEWS: Pfizer outlook downbeat as swings to loss in third quarterLSE:0Q1NPfizer Inc
20/10/202320:25Alliance NewsAlliance NewsUS FDA approves Pfizer's Penbraya for meningococcal diseaseLSE:0Q1NPfizer Inc
19/10/202315:37Alliance NewsAlliance NewsEU clears Pfizer's USD43 billion takeover of biotech firm SeagenLSE:0Q1NPfizer Inc
 Showing the most relevant articles for your search:LSE:0Q1N

Your Recent History

LSE
VAST
Vast Resources
LSE
TPL
Tethys
LSE
NESF
Nextenergy Solar
LSE
POS
Plexus
NASDAQ
SMCI
Super Micro Computer
LSE
OCDO
Ocado
LSE
MIN
Minoan
LSE
LLOY
Lloyds Banking
LSE
CPI
Capita
LSE
SYME
Supply@me Capital
LSE
ITV
Itv
LSE
GGP
Greatland Gold
LSE
SCLP
Scancell
LSE
CARD
Card Factory
LSE
JLP
Jubilee Metals
LSE
NFDS
Northern Foods
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06